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Research
Toxic metals are ubiquitous in the environ-
ment and are known to cause detrimental 
health effects. Exposure to toxic metals during 
the pre natal period is of particular concern, and 
exposure can occur as a result of diet, drink-
ing water, airborne particles, consumer prod-
ucts, and certain occupational environ ments 
(Tabacova 1986). Evidence suggests that many 
toxic metals indeed cross the placental barrier 
(Al-Saleh et al. 2011; Casey and Robinson 
1978; Concha et al. 1998; Guo et al. 2010; 
Rudge et al. 2009) and are thus likely to have a 
detrimental impact on the developing fetus.
The focus of the present study was to 
select seven high-priority toxic metals and/or 
metal loids on the basis of their presence in the 
environment and their known or suspected 
roles as develop mental toxicants. The follow-
ing metals were selected for study: cadmium 
(Cd), chromium (Cr), inorganic arsenic (iAs), 
lead (Pb), mercury (Hg), nickel (Ni), and sele-
nium (Se). Four of these—Cd, Hg, iAs, and 
Pb—are ranked in the top 10 most hazardous 
substances by the Agency for Toxic Substances 
and Disease Registry (ATSDR 2010). Several 
of these metals have been associated with 
structural malformations and/or neural tube 
defects in animal models (Chaineau et al. 1990; 
Fernandez et al. 2004; Gilani and Marano 
1980; Gruenwald 1958; Hovland et al. 1999; 
Messerle and Webster 1982; Tabocova et al. 
1996; Thompson and Bannigan 2001). In 
addition to the toxicological data, several epi-
demiological studies have also examined the 
relation ship between metal exposure and early 
life outcomes in infants. For example, prenatal 
exposure to iAs in drinking water has been asso-
ciated with adverse pregnancy outcomes such as 
spontaneous abortion, stillbirth, pre term birth 
(Ahmad et al. 2001), and congenital malforma-
tions (Kwok et al. 2006; Zierler et al. 1988).
Clearly, there is public health concern sur-
rounding environmental exposure–mediated 
birth defects, which is supported by both epi-
demiological and animal-based evidence. Still, 
the underlying patho physiological mechanisms 
linking pre natal exposures to develop mental 
disorders remain largely unknown. In the pres-
ent study we set out to test the hypothe sis that 
biological pathways that mediate metal-induced 
birth defects could be revealed by identifying 
common signaling pathways that integrate both 
metal- and development-associated genes. We 
applied a systems biology approach coupled 
with a teratogenic experimental strategy.
Specifically, the research framework 
included a) the identification of gene–
contaminant relationships from a comparative 
toxicogenomics database; (b) the prediction 
of biological pathways associated with metals 
exposure and developmental disorders; and 
c) laboratory-based validation of the in silico 
pathway prediction. This novel computational 
approach was applied to the seven metals of 
interest and resulted in the prediction that 
the glucocorticoid receptor (GR) signaling 
pathway may be a key mediator that is highly 
associated with four of the selected metals: Cd, 
Hg, iAs, and Se. Focusing on this pathway, we 
used the in ovo chick embryo culture model 
to demonstrate that structural malformations 
induced by one of the metals, iAs, can be 
prevented through blockade of the GR signaling 
pathway. In addition, we used an in vitro 
micromass (MM) culture assay to demonstrate 
that neuro developmental toxicity induced 
by iAs and Cd was partially or completely 
prevented by blocking the pathway. Our results 
provide evidence for a novel systems biology 
strategy by which biological pathways can be 
predicted and subsequently tested to increase 
our understanding of patho physiological 
mechanisms related to birth defects.
Materials and Methods
Identifying metal-associated genes. To iden-
tify genes known to be associated with the 
metals of study, we used the Comparative 
Toxicogenomics Database (CTD 2011; 
Davis et al. 2011). The CTD is a manu-
ally curated toxico genomic database. At 
the time of analysis, it included > 178,000 
interactions between 4,980 chemicals and 
16,182 genes/proteins in 298 species. It 
contains 8,900 gene/protein–disease direct 
relationships and 5,600 chemical–disease 
relationships (CTD 2011; Davis et al. 2011). 
We used the CTD Batch Query tool (CTD 
2011) to retrieve all curated chemical–gene/
protein inter actions for each of the seven 
selected metals: Cd, Cr, Hg, iAs, Ni, Pb, and 
Se. In addition, the CTD was used to identify 
genes/proteins associated with phenytoin, a 
well-known human teratogen (Buehler et al. 
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1990), which served as a positive control for 
the in ovo experiments.
Identifying metal-associated genes with 
roles in development. Once metal-associated 
genes/proteins were identified using the CTD 
database, we performed biological function 
enrichment analysis using Ingenuity Pathway 
Analysis (IPA) software (Ingenuity Systems, 
Redwood City, CA). Specifically, genes with 
known involvement in embryonic develop ment 
and develop mental disorders were identified 
and referred to as “development” associated.
Predicting pathways involved in metal-
induced developmental disorders. Molecular 
networks related to metal-associated genes 
involved in development were identified using 
IPA. This knowledge database provides a 
collection of gene-to-pheno type associations, 
molecular inter actions, regulatory events, 
and chemical knowledge accumulated to 
develop a global molecular network. In IPA, 
metal-associated genes were mapped to their 
global molecular networks, and networks 
integrating proteins encoded by the metal- 
and development-associated genes were 
algorithmically generated based on their 
connectivity. Pathway enrichment analysis 
was performed to identify canonical pathways 
significantly associated with constructed 
networks. Statistical significance of each 
constructed network was evaluated using 
Fisher’s exact test.
In ovo whole chick embryo culture. The most 
significant canonical pathway identified through 
network analysis was ranked and validated for its 
involve ment in embryonic development using 
the chick embryo model. Specifically, we used 
in ovo whole chick embryo culture assay, a well-
established model for teratogenicity assessment 
(Kucera et al. 1993), to test the computational 
prediction that the GR signaling pathway is 
involved in metal-induced developmental dis-
orders. All experimental procedures were con-
ducted on embryos < 10 days of age and thus 
were exempt from oversight by the University 
of North Carolina Institutional Animal Care 
and Use Committee. We obtained fertilized 
white leghorn chicken eggs from Charles River 
Laboratories (North Franklin, CT, USA). Eggs 
were randomly selected and divided into seven 
different treatment groups immediately before 
incubation. The treatment groups were as fol-
lows: control [phosphate-buffered saline (PBS) 
only]; vehicle control (0.1% ethanol); pheny-
toin, a positive control for neural tube defects 
(Fisher Scientific); iAs as sodium arsenite (iAs3+; 
Sigma-Aldrich, St. Louis, MO); cortexo lone, a 
GR inhibitor (Fisher Scientific); phenytoin plus 
cortexolone; and iAs3+ plus cortexolone. We 
selected the concentration of cortexolone on the 
basis of previous studies (Harlow et al. 1987; 
Turnell et al. 1974).
Ten to 12 embryos were examined per 
treatment group in four independent biological 
replicates. Eggs were incubated at 100°F at 
a relative humidity of 55%, with the day on 
which the eggs were incubated counted as 
day 0. The eggs were dosed on day 3 of incuba-
tion. First, the eggs were swabbed with 70% 
ethanol and the blunt end of the eggs was stuck 
with forceps to make a small hole, following 
an established protocol (Kucera et al. 1993; 
Memon and Pratten 2009). Eggs were injected 
with 100 µL of either PBS alone, vehicle (0.1% 
ethanol), phenytoin (400 µM), iAs3+ (0.1 µM, 
or 7.5 ppb), cortexolone (2 µM), phenytoin 
plus cortexolone, or iAs3+ plus cortexolone, and 
then incubated until day 6. On day 6, embryos 
were removed and analyzed for gross malfor-
mations and scored according to established 
morphological scoring criteria (described by 
Memon and Pratten 2009) [see Supplemental 
Material, Table S1 (http://dx.doi.org/10.1289/
ehp.1205659)]. Only viable embryos, defined 
by the presence of a beating heart and visibly 
circulating blood in the embryo and yolk sac, 
were included and assigned morphological 
scores. Crown–rump length was taken as a 
measure of embryo growth.
Data were analyzed using Graphpad 
Prism 5 software (Graphpad Software Inc., 
San Diego, CA). To assess the morphological 
scoring criteria (vitelline circulation, flexion, 
heart, brain, gross facial deformities, and limbs) 
between exposure groups, we used Kruskal-
Wallis one-way analysis of variance (ANOVA) 
followed by Mann-Whitney U-test for non-
parametric data. The statistical process was car-
ried out as described by Hewitt et al. (2005). 
The means ± SEs of the morphological scores 
were determined for the four independent 
experiments. Embryo growth, as measured by 
crown–rump length, was analyzed using para-
metric statistical tests (ANOVA followed by 
Dunnett’s post hoc test). Statistical significance 
was set at p < 0.05. 
Quantitative reverse-transcription poly-
merase chain reaction (qRT-PCR). We assessed 
the gene expression levels of two transcription 
factors, NF-κB1 (nuclear factor kappa B1) 
and AP1 (activating protein 1). AP1 com-
prises c-FOS and c-JUN, and these genes were 
assessed relative to glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) using qRT-PCR; 
primer sequences are shown in Supplemental 
Material, Table S2 (http://dx.doi.org/10.1289/
ehp.1205659). Total RNA was isolated from 
the whole head regions of treated and untreated 
embryos (n = 3 embryos/group) using an 
RNeasy® Mini Kit (QIAGEN, Valencia, CA). 
RNA was quantified with the NanoDropTM 
1000 Spectrophotometer (Thermo Scientific, 
Waltham, MA), and integrity was veri-
fied with a model 2100 bioanalyzer (Agilent 
Technologies, Santa Clara, CA). Fold changes 
between the treatment group and the control 
group were calculated using delta-delta cycle 
threshold (∆∆Ct) values and normalized with 
GAPDH as a housekeeping gene. Statistical 
significance of the transcript levels between 
treatment groups versus the control group was 
calculated using an unpaired t-test.
Chick embryo midbrain micromass (MM)
culture in vitro assay. We further evaluated the 
role of the GR pathway as a mediator of metal-
induced neuro developmental toxicity using the 
in vitro chick embryo MM culture assay. The 
midbrain MM culture assay is a well-accepted 
method to screen for develop mental toxicity 
of compounds, and was performed according 
to previously established protocols (Flint and 
Orton 1984; L’Huillier et al. 2002). Midbrains 
were removed from chick embryos on day 6 
and trypsinized to prepare single-cell suspen-
sions in Ham’s F12 culture medium containing 
10% fetal calf serum, 200 mM l-glutamine, 
penicillin (50 units/mL), and strepto mycin 
(50 µg/mL). Cell density was estimated using 
a hemo cytometer and adjusted to 1 × 106 
cells/mL. A total of 10 µL of the cell suspen-
sion was pipetted into the center of a collagen-
coated well in a 96-well culture plate. After 
24 hr, midbrain MM cultures were treated 
with iAs3+ (1, 2, or 5 µM), Cd as CdCl2 (1, 2, 
5, or 8 µM), phenytoin (100 µM), cortexolone 
(2 µM), cortexolone plus iAs3+, cortexolone 
plus CdCl2, cortexolone plus phenytoin. The 
assay included positive and negative con-
trols for cyto toxicity, namely, 5-fluorouracil 
(5-Fu) and penicillin G (PenG), respectively. 
Midbrain MM culture cyto toxicity was mea-
sured after 5 days in culture using the one-step 
resazurin reduction assay (O’Brien et al. 2000). 
Optical density was measured on a Synergy™ 
HT Multi-Mode Microplate Reader (BioTek, 
Winooski, VT), with an excitation filter 
530 ± 25 nm and emission filter 590 ± 35nm 
indicating cell viability and metabolic activ-
ity. Statistical analysis was performed using 
Graphpad Prism 5 software. We used Student’s 
t-test for comparison between two groups and 
one-way ANOVA followed by an appropriate 
post hoc test (e.g., Dunnett or Bonferroni) for 
comparisons among groups. A p-value < 0.05 
was considered statistically significant.
Results
We used a novel approach to identify biological 
pathways that may mediate environmentally 
induced birth defects. Specifically, our strat-
egy involved using the CTD to identify genes 
associated with environ mental metals, filtering 
these genes for biologi cal function related to 
birth defects and develop ment, and examining 
the genes for known biologi cal interactions in 
the cell [see Supplemental Material, Figure S1 
(http://dx.doi.org/10.1289/ehp.1205659)].
Metal- and development-associated genes 
identified. The in silico approach first involved 
the identification of genes associated with 
seven metals: Cd, Cr, Hg, iAs, Ni, Pb, and Se. 
Genes with known association to the metals 
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of interest were identified using the CTD [see 
Supplemental Material, Table S3 (http://
dx.doi.org/10.1289/ehp.1205659)]. The CTD 
contains data on broad relation ships between 
genes and environ mental toxicants (we que-
ried for metals), known effects of toxicants on 
gene expression, and genes encoding proteins 
that have altered metal-associated changes 
in protein abundance and protein activity. 
Thus, all genes identified had a known rela-
tionship with at least one of the seven metals: 
Cd (n = 518 genes), Cr (n = 175 genes), Hg 
(n = 334 genes), iAs (n = 1,880 genes), Ni 
(n = 637 genes), Pb (n = 774 genes), and Se 
(n = 1,616 genes) (see Supplemental Material, 
Tables S3 and S4). In addition, genes associ-
ated with phenytoin, a known teratogen, were 
identified as a positive control (n = 138) (see 
Supplemental Material, Tables S3 andS4).
The lists of metal-associated genes were 
subsequently filtered for genes/proteins with 
known relationships to organismal develop-
ment and birth defects. Specifically, we 
performed biological function enrichment 
analysis; genes related to either “embryonic 
develop ment” or “developmental disorders” 
were identified and extracted from the lists. 
The resultant numbers of genes that were 
identified as both metal- and development-
associated ranged from 76 for Cr to 604 for 
iAs [see Supplemental Material, Tables S3 and 
S5 (http://dx.doi.org/10.1289/ehp.1205659)]. 
Predicting pathways influencing metal-
induced developmental disorders. Biological 
pathways that were enriched among the metal- 
and development-associated genes were algo-
rithmically constructed. For each of the metals 
and for phenytoin, we selected the highest 
ranking (e.g., top five) canonical pathways. 
Because of some overlap, this resulted in a total 
of 22 unique canonical pathways [Figure 1; 
for a complete list of all top-ranking pathways 
and their p-values, see Supplemental, Table S6 
(http://dx.doi.org/10.1289/ehp.1205659)]. 
The pathway analysis revealed that, in gen-
eral, distinct pathways were highly enriched 
among genes associated with each of the met-
als (Figure 1). Still, many of the pathways were 
enriched between two or more metals. The GR 
signaling pathway was a high ranking canoni-
cal pathway for Cd, Hg, iAs, and Se. Notably, 
this indicates that genes associated with these 
four metal- and development-associated genes 
commonly mapped to the GR signaling path-
way. Networks associated with phenytoin, 
a known teratogen, also showed significant 
enrichment for biological pathways that over-
lapped with those associated with metal expo-
sure, including the GR signaling pathway. 
Other pathways of interest were identified as 
being related to the metal- and development-
associated genes, such as the aryl hydrocarbon 
receptor (AHR) pathway identified for Cr and 
phenytoin (Figure 1).
To further establish environmental expo-
sure–mediated network interactions, we per-
formed a subsequent analysis using a combined 
list of all the metal- and development-associated 
genes together (n = 855 genes). Within the 
resulting metal-associated networks, the GR 
signaling pathway was the most significantly 
(p < 10–6) enriched pathway [see Supplemental 
Material, Figure S2 (http://dx.doi.org/10.1289/
ehp.1205659)]. Many of the genes that encode 
proteins involved in the canonical GR signaling 
pathway have known association with numer-
ous metals as defined in the CTD. For exam-
ple, NF-κB1, a protein involved in the GR 
signaling pathway, has a known relationship to 
six of the seven metals (CTD 2011). Likewise, 
AP1 (composed of c-FOS and c-JUN) and 
c-JUN N-terminal kinase (JNK) are also asso-
ciated with multiple metals (CTD 2011) (see 
Supplemental Material, Figure S2).
Validation of computational prediction by 
the embryo culture assay. Given the computa-
tional analysis predicting association of Cd, Hg, 
iAs, and Se with the GR signaling pathway, we 
set out to validate the findings using an in ovo 
whole chick embryo culture assay. Our hypoth-
esis was that the GR mediates metal-induced 
develop mental defects. iAs was prioritized for 
testing, and results were compared to those 
of phenytoin, a GR-dependent teratogen 
(Kay et al. 1990). A total of 10–12 embryos 
per treatment group were examined in four 
 independent biological replicates.
Phenytoin, the positive teratogenic control, 
induced malformations in 56% of the embryos, 
and iAs induced malformations in 59% 
(Table 1). No phenotypic abnormalities were 
observed in embryos treated with PBS or the 
vehicle control (Figure 2A, Table 1). For phe-
nytoin and iAs, observed morphological defects 
included abnormalities in the head fold region, 
microcephaly, anterior neural tube defects, and 
gross facial deformities (Figure 2B,C). The 
cranio facial defects included altered optic and 
beak development and malformed facial arches. 
The in ovo exposures of chick embryos to iAs 
and phenytoin also induced lethality in 24% of 
the embryos (Table 1).
To specifically test the in silico prediction 
that the GR signaling pathway mediates the 
occurrence of structural birth defects caused 
by iAs, the GR pathway was blocked using 
the inhibitor cortexolone. Embryos exposed 
to cortexolone alone or to phenytoin plus 
Figure 1. Canonical pathways associated with metal exposure and developmental disorders. A total of 
22 canonical pathways found to be highly enriched in genes/proteins for at least one of the selected metals 
or phenytoin (PHT; the positive control), as identified in lists retrieved from the CTD. Colors denote pathways 
that were (red) or were not (blue) within the top five canonical pathways for that metal or phenytoin. 
Abbreviations: AKT, serine/threonine-specific protein kinase; HIF-1α, hypoxia-inducible factor 1, alpha 
subunit; IL-8, interleukin 8; PI3K, phosphoinositide 3-kinase. 
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cortexolone had no gross structural malforma-
tion and developed normally (Figure 2D,E, 
Table 1). Suprisingly, embryos exposed to iAs 
plus cortexolone showed no gross structural 
malformations and displayed normal growth 
parameters (Figure 2F, Table 1). 
Embryo growth (crown–rump length) 
was significantly (p < 0.05) decreased in 
phenytoin-exposed and iAs-exposed embryos 
compared with controls, whereas cortexolone-
treated embryos developed normally and were 
comparable to the control group (Figure 3A). 
In addition, statistical analyses of other mor-
phological scoring criteria showed a significant 
difference (p < 0.05) between iAs or phenytoin 
and the control groups for vitelline circulation, 
flexion of the embryo, brain development, 
and craniofacial development (Figure 3B–E). 
No gross malformations were detected in 
heart or limbs for any treatment group [see 
Supplemental Material, Figure S3A,B (http://
dx.doi.org/10.1289/ehp.1205659)].
Mediation of iAs-induced gene expression 
changes by GR. To validate that iAs influences 
gene expression via the GR pathway in the 
developing chick, we performed qRT-PCR. 
We assessed the expression levels of two 
transcription factors, NF-κB1 and AP1, in the 
head regions of the embryos. NF-κB1 (fold 
change = 3.85) and c-FOS (fold change = 5.66) 
were up-regulated in embryos treated with 
iAs (0.1 µM) [see Supplemental Material, 
Figure S4A,B (http://dx.doi.org/10.1289/
ehp.1205659)]. Embryos treated with iAs 
plus cortexolone showed restored levels of 
NF-κB1 (p < 0.01) and c-FOS (p < 0.05) (see 
Supplemental Material, Figure S4A,B). In 
phenytoin-treated embryos, gene expression 
levels of NF-κB1 and c-JUN were not 
significantly changed, but c-FOS expression 
was increased. Surprisingly, cortexolone did not 
block the effects of phenytoin on the expression 
level of c-FOS. These results suggest that other 
genes/proteins in the GR signaling pathway may 
influence phenytoin and cortexolone and their 
interactions in this model system. The increased 
c-JUN expression level was not statistically 
signifi cant in any of the treatment groups (see 
Supplemental Material, Figure S4C).
Mediation of iAs and Cd-induced neuro-
developmental toxicity by the GR pathway. 
The GR pathway was predicted to mediate the 
response to Cd, Hg, iAs, and Se. Thus, as a 
further test of the role of the GR in mediating 
metal-induced neurodevelopmental toxicity, 
we chose to test Cd as well as iAs. Embryonic 
chick midbrain MM cultures were exposed 
to iAs (1–5 µM), Cd (1–8 µM), phenytoin 
(100 µM), or cortexolone (2 µM). We used 
5-Fu and PenG, respectively, as positive and 
negative controls for cytotoxicity. The 8 µM 
concentration of 5-Fu resulted in a sig-
nificant (p < 0.01) reduction in cyto toxicity 
(Figure 3F). This suggests that differentiating 
midbrain MM cultures were susceptible to the 
toxic effects of 5-Fu at this concentration. As 
expected, PenG was not cytotoxic to the mid-
brain MM cultures. Exposure of the cultures to 
phenytoin or phenytoin plus cortexo lone did 
not result in any cytotoxicity. This is consistent 
with the results of Regan et al. (1990), who 
observed no cytotoxic effects in primary neu-
ronal cells treated with this concentration of 
phenytoin. We observed a significant decrease 
in the viability of embryonic mid brain cells 
treated with 2 and 5 µM iAs or 5 and 8 µM 
Cd (Figure 3F). Cortexolone-treated cells, with 
inhibited signaling of the GR pathway, were 
protected from cyto toxicity induced by 2 µM 
iAs. At the highest iAs concentration (5 µM), 
midbrain MM cultures were partially protected 
from iAs-induced cyto toxicity. Cortexolone 
completely protected the midbrain cells from 
the cytotoxic effects of Cd (Figure 3F).
Discussion
Congenital malformations are the leading cause 
of infant mortality. An estimated 120,000 
infants are born with severe congenital mal-
forma tions each year in the United States 
(Brent 2004). Of all the congenital mal-
forma tions, 60–70% are caused by unknown 
environ mental and/or genetic causes (Moore 
and Persaud 1998). Thus, there is a need for 
effective methods to identify biological path-
ways that are patho physiologically related 
to birth defects. There is great promise that 
systems biology can be used to identify 
biologi cal pathways that relate environmental 
contaminants with human development/
diseases (Chuang et al. 2010) and birth defects 
(Sperling 2011).
In the present study, we developed an 
in silico strategy to aid in the understanding of 
metal-induced birth defects. To investigate the 
relationship between metal exposures and birth 
defects, we applied this novel approach whereby 
genes associated with seven selected metals were 
identified using the CTD. To identify genes 
with any known relationship to birth defects, 
the CTD-retrieved gene/protein data sets were 
then filtered for only those genes with known 
associations to embryonic develop ment or 
developmental disorders. Biological pathways 
associated with developmental dis orders were 
further elucidated using a systems-level analysis.
Although other studies have used the 
CTD to identify metal-perturbed pathways 
(Davis et al. 2008; Mattingly et al. 2009), we 
introduced a health outcome filter to enrich 
for relationships to structural birth defects that 
may result from exposure to toxic metals. The 
metal- and development-associated genes were 
highly enriched for 22 canonical pathways, 
many of which were common to multiple 
metals. For example, the GR signaling path-
way was identified as a top ranking pathway 
for Cd, Hg, iAs, and Se. In addition, the GR 
pathway was also generally enriched in the 
genes/proteins identified for Cr, Ni, and Pb. 
Figure 2. Photographs of representative embryos from each treatment group showing morphological fea-
tures of chick embryos treated in ovo. Developmental end points were assessed between treatment and 
control groups on day 6. (A) Control (PBS-treated) embryo showing the development of forebrain (FB), 
midbrain (MB), hindbrain (HB), eye (E), heart (H), fore limb buds (FL), and hind limb buds (HL). (B) Phenytoin 
(PHT)-treated embryo exhibiting an abnormal head shape, failure of closure of the anterior part of the neural 
tube (+), and craniofacial defects (*). (C) iAs3+-treated embryo exhibiting craniofacial and anterior neural tube 
defects (anencephaly) (#). Embryos treated with (D) cortexolone (CX), (E) PHT plus CX, or (F) iAs3+ plus CX (F). 
Bar = 2 mm. 
2 mm 2 mm 2 mm
2 mm 2 mm 2 mm
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This finding is supported by other reports that 
metals, including Cd, Cr, Hg, iAs, Pb, and Se, 
influence signaling of the GR signaling path-
way (Webster Marketon and Sternberg 2010). 
Although these metals have been shown to 
be associated with the GR, the role of this 
pathway in mediating metal-induced develop-
mental defects is under studied. In addition to 
the GR pathway, other pathways, such as that 
mediated by AHR, were significantly enriched 
for Cr and for phenytoin. These findings sug-
gest other biological pathways that warrant 
future follow-up. These results may also pro-
vide a means by which biological pathways 
that mediate the developmental defects of 
metals are prioritized for study.
In general, structural birth defects are 
believed to result from complex mechanisms, 
including multiple genes and signaling path-
ways (Mitchell 2005). The GR pathway 
exemplifies this complexity and is composed 
of pro-inflammatory cytokines, enzymes, cell 
adhesion molecules, and transcription factors 
such as NF-κB1 and AP1. Our results show 
that many of the genes/proteins involved in 
the GR pathway are enriched for interactions 
of two or more of the metals. For example, 
NF-κB1 is associated with Cd, Hg, iAs, Ni, 
Pb, and Se (CTD 2011).
We postulated that the GR signaling 
pathway may be a biological pathway that 
associates metals with resultant structural 
birth defects. To test this computational 
prediction, we priori tized one of the selected 
study metals for testing using the whole chick 
embryo culture in ovo model. We selected iAs 
for further investigation because it is a well-
established develop mental toxicant and is listed 
as the highest priority hazardous substance 
by the ATSDR (2010). iAs can readily cross 
the human placenta and accumulate in fetal 
neuro epithelium junction, thereby plausibly 
inducing various developmental defects 
(Wlodarczyk et al. 1996, 2006).
In the present study, we observed that low 
levels of iAs (0.1 µM, or 7.5 ppb) induced 
structural birth defects including micro cephaly, 
anterior neural tube defects (anencephaly), and 
gross cranio facial defects in the chick embryo. 
These results are similar to those from previ-
ous studies that showed iAs-induced structural 
malformations in the chick (Han et al. 2011) 
and mouse embryo models (Chaineau et al. 
1990; Tabocova et al. 1996). The iAs-induced 
malformations in mouse have also been shown 
to be associated with systems-level changes in 
gene expression (Robinson et al. 2011).
Although strong evidence demonstrates 
the teratogenic effects of iAs in animal models, 
debate remains as to the effects on human con-
genital malformation (DeSesso 2001; Golub 
et al. 1998; Holson et al. 2000). Potential 
epidemiologic associations relating iAs with 
birth defects have been reported in human 
populations (Kwok et al. 2006; Zierler et al. 
1988). For example, iAs-associated low birth 
weight has been previously demonstrated in 
human populations (Hopenhayn et al. 2003). 
The iAs concentration used in the present 
study is within the 10 ppb (0.13 µM) maxi-
mum allowable level of arsenic in U.S. public 
drinking water supplies (U.S. Environmental 
Protection Agency 2012).
The mechanism by which iAs induces 
structural birth defects in animal models 
is largely unknown. Given the results of our 
computational analyses, we postulated that iAs 
may induce birth defects via the GR signaling 
pathway. To test this, we used the known GR 
inhibitor cortexolone. Cortexolone binds to 
the GR and leads to an altered conformational 
Figure 3. Embryonic growth, morphological scores, and toxicity of chemical compounds in whole chick embryos cultured in ovo (incubation day 3–6). Crown–rump 
length (A), vitelline circulation (B), flexion (C), brain (D), and gross facial deformities (E) of embryos treated with PBS (control), vehicle control (0.1% ethanol), pheny-
toin (PHT), iAs3+, cortexolone (CX), PHT plus CX, or iAs3+ plus CX. (F) Effects of iAs3+ and Cd (CdCl2) on cell viability of midbrain MM cultures 5 days after exposure; 
positive and negative controls for cytotoxicity were 5-Fu and PenG, respectively. Data represent the means ± SEs from four independent experiments (n = 4). 
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form of the GR complex, which is then trans-
ported into the nucleus (Kaiser et al. 1972). 
We observed that blockade of the GR pathway 
indeed prevents the iAs-induced cranio facial 
and neural tube defects. Others have reported 
that cortexolone successfully reduces the occur-
rence of phenytoin-induced birth defects in 
mouse embryos (Kay et al. 1990). Cortexolone 
also prevents GR-mediated teratogenicity (e.g., 
cleft palate, limb defects) in chick embryos 
(Jelinek et al. 1983; Pavlik et al. 1986). To our 
knowledge, no previous studies have exam-
ined GR blockade as a means for prevention of 
metal-induced birth defects.
Our results show a relationship among 
iAs, birth defects, and the GR pathway. iAs 
has a biphasic effect on GR function and dis-
rupts GR-mediated transcription in a com-
plex fashion. Specifically, very low doses of 
iAs (e.g., 0.01 µM, or 0.7 ppb) have been 
shown to alter the function of the GR as a 
transcription factor, enhancing GC induction 
of endogenous GR-regulated genes (Bodwell 
et al. 2004; Davey et al. 2007; Kaltreider et al. 
2001). Studies have also shown that low doses 
of iAs (e.g., 0.1 µM, or 7.5 ppb) can interfere 
with hormone receptor binding and can act 
as a potent endocrine disruptor of hormone- 
mediated gene transcription by the GR 
(Bodwell et al. 2004, 2006; Davey et al. 2007; 
Kaltreider et al. 2001). Furthermore, iAs causes 
altered signaling via oxidative stress induction, 
which can damage DNA in cells by turning on 
heat shock protein production (Hughes 2002). 
Through these mechanisms, iAs may acti-
vate GR-mediated gene transcription. Several 
studies have demonstrated that iAs enhances 
NF-κB1 and AP1 DNA binding and induces 
stress responsive transcription factors that may 
play important roles in iAs-induced signal 
transduction, cell transformation, and apopto-
sis (Dong 2002; Drobna et al. 2003; reviewed 
by Zeng et al. 2005). In the present study, we 
examined the expression levels of GR-mediated 
NF-κB1 and AP1 and found that iAs increased 
their expression levels in the head region of the 
deformed chick. Their expression levels were 
muted in the presence of cortexolone, indicat-
ing that iAs influences the expression of these 
genes via the GR pathway. It is important to 
note that phenytoin, the GR-specific control, 
failed to impact the expression of NF-κB1, 
with only c-FOS showing a statistically sig-
nificant change. These data suggest complex 
signaling responses to phenytoin that may act 
on other genes within the GR pathway.
GC-associated effects are mediated 
through the GR. Several possible mechanisms 
can cause the disruption of the GR signaling 
pathway, such as excessive amounts of GCs 
leading to intrauterine growth retardation and 
low birth weight (Drake et al. 2007). In the 
fetus, unmetabo lized GCs appear to func-
tion as the active teratogenic agent (Goldman 
et al. 1978; Pratt 1985). GCs can also influ-
ence glycolysis via a GR-mediated mechanism 
(Loiseau et al. 1985). Evidence suggests that 
GC terato genicity is a result of direct action on 
the embryo, which triggers a characteristic pat-
tern of dys morpho genesis via the biochemical 
and GC-mediated anti-inflammatory pathway 
(Kay et al. 1990; Pratt 1985).
The in silico results presented here indicate 
that not only iAs but other metals, such as Cd, 
may also act through the GR. To examine the 
links between the GR pathway and these two 
separate metals, we further assessed the toxicity 
of iAs or Cd in midbrain MM culture, an estab-
lished method to assess the effects of develop-
mental toxicants (L’Huillier et al. 2002). The 
results demonstrate that inhibition of GR sig-
naling partially protected against iAs-induced 
cytotoxicity at the highest dose, while complete 
protection was observed at the lower doses. 
GR blockade completely protected against 
Cd-induced cellular toxicity. These data support 
the prediction that metals other than iAs also 
act via the GR pathway. Taken together, the 
results from this study show that iAs-induced 
structural birth defects are dependent on signal-
ing through the GR pathway (Figure 4). These 
findings highlight an in silico method useful for 
the selection of a targeted biological pathway 
to test for birth defects prevention. The results 
suggest a plausible patho physiological mecha-
nism by which iAs alters the GR pathway to 
ultimately cause birth defects.
Conclusions
We used a systems biology–based compu-
tational approach to determine that the GR 
pathway is a highly enriched pathway inte-
grating a panel of metals (e.g., Cd, Hg, iAs, 
Se) with birth defect–associated genes. On 
the basis of the computational prediction, 
we used a GR inhibitor to demonstrate that 
iAs-induced structural malformations can 
be prevented in the chick embryo model. In 
addition, iAs- and Cd-induced neuro develop-
mental toxicity were partially or completely 
Figure 4. Proposed model for iAs-induced birth defects via the GR pathway. iAs appears to induce birth 
defects in the chick embryo as a result of signaling through the GR [also known as NR3C1 (nuclear recep-
tor subfamily 3, group C, member 1)] pathway. Gene members of the GR pathway are shown in red (associ-
ated with embryonic development) or green (associated with developmental disorders). In embryos with 
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protected via GR pathway inhibition assessed 
using the midbrain MM culture assay. Thus, 
these results illustrate the potential use of 
systems biology–based predictions in teratol-
ogy and developmental toxicology research. 
We anticipate that this novel strategy can be 
employed to predict other biological pathways 
that mediate environmentally induced birth 
defects. Moreover, as applied to environmen-
tal metals, this type of cost-effective approach 
could be applied to a wide range of other envi-
ronmental contaminants. These data provide 
novel information that may be useful in the 
prevention and treatment of metal-induced 
birth defects.
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